// home

Latest Post

IC2 expected on the international market from September 1st, 2011 – You can order now!

The IC2 monoclonal autoantibody and its biotinylated, HRP, FITC and PE conjugated formats are planned to be commercial available from September 1st, 2011 after stability and quality control.  Antibody-online.com will on commission contract with ImmunoSigns do both marketing and sale, but the products will also be directly available from ImmunoSigns in Copenhagen directly from this […]

Welcome to ImmunoSigns

ImmunoSigns is a Biotech company founded in 1996. We offer you help in project management and R&D activities within biotechnology and immunodetection.

The core competance of ImmunoSigns is development and production of polyclonal and monoclonal antibodies and design and production of novel immunoassays and diagnostic kits, especially within the clinical area of diabetes and obesity.

Shopping Cart